3rd Jun 2014 08:12
LONDON (Alliance News) - Cambridge Cognition Holdings PLC said Tuesday that it had launched the first of its two iPad-based products on its Cantab Connect digital platform for use in clinical trials. Its product, called The Clinical Trials Information System Adverse Effects, allows for the Read More